You are here
Update on Primary Therapy, Second-Line Therapy, and New Agents for Chronic Myelogenous Leukemia
NCCN 2nd Annual Congress: Hematologic Malignancies - Update on Primary Therapy, Second-Line Therapy, and New Agents for Chronic Myelogenous Leukemia (Slides with Audio) CME/CE
Jerald P. Radich, MD
Radich, MD